Skip to content

A clinical trial to study the effectof two drugs Aabhadi Churna Vati and Lakshadi Guggul in patients with sandhivata

A randomized controlled clinical study to evaluate the efficacy of Aabhadi Churna Vati in the management of Dhatukshayajanya Janu Sandhigatvat in age group 40 to 70 years - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080022
Enrollment
80
Registered
2025-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

None listed

Sponsors

PDEAs College of Ayurved and Research Centre pradhikaran Nigdi pune
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having classical sign and symptoms of Dhatukshayjanya Janusandhigatvat (If any 3 present) 2. Janusandhi Shula (Pain) 3. Janusandhi Shotha (Swelling) 4.Janusandhi Graha(stiffness) 5.Janusandhi Sphutana (Crepitus) 6. Patients of either sex aged between 40 to 70 years 7. X-Ray of knee joint suggestive of degenerative changes

Exclusion criteria

Exclusion criteria: 1.Major systemic disorders - cancer, cirrhosis of liver,kidney failure 2.Patients with known case of Rheumatoid arthritis, Psoriatic arthritis,Gouty arthritis,Systemic lupus erythematous,Bone tuberculosis,Previous knee surgeries,knee implants 3. Known case of Fracture of knee joint. 4. Known case of direct and indirect infection of knee joint 5.history of any surgical procedure of knee joint

Design outcomes

Primary

MeasureTime frame
To compare effectiveness of Aabhadi Churna vati 500mg at vyanodan kala with koshnajala for 60 days and Lakshadi Guggul 500mg at vyanodan kala with koshnajala for 60 days in the management of Dhatukshayajanya Janu SandhigatvatTimepoint: 60 days with follow up 15th 30th 45th 60th

Secondary

MeasureTime frame
To observe the adverse effect if anyTimepoint: 60 days with follow up 15th 30th 45th 60th

Countries

India

Contacts

Public ContactDr Aditya Dilip Kale

PDEAs College of Ayurved and Research Centre

taksaleabhishek@gmail.com9011061293

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026